The aim is to place healthy hepatic cells into biodegradable biopolymers (such as poly-lactide-co-glycolide), implant them into laboratory animals and demonstrate that the cells survive and function in these animals.
Development of new antibacterial additives, fibres and textile materials designed for protection of humans against pathogenic microorganisms.
Development of the use of tumour necrosis factor related apoptosis inducing ligand or apo2 ligand (trail) as an efficient anti-tumour therapy as an alternative to chemo/radiotherapy.
Description, comparison with clinical data and clinical exploitation of a non-invasive and relatively inexpensive method for screening cardiovascular systems based on multi-parameter analysis of heart haemodynamics and vascular perfusion in selected areas of the body.
Development of apple cultivars with resistance to diseases and better fruit quality by combining traditional methods of apple breeding with the most recent selection technologies using molecular tools.
Using well-characterized antibodies to form the basis for the development of diagnostic kits to monitor neurodegenrative processes.
Development of a new, innovative medical apparatus for the artificial ventilation of lungs of intensive care patients and as extra support during emergencies (e.G. Terrorist attack or natural disaster).
Development of new tools for tumour detection to link distant experts through computer assisted diagnosis, and planning and training of minimal invasive surgery through cooperative virtual reality and robotic systems.
Efficient control strategies against phytoplasma vectoring psyllids will be established by the help of molecular markers to study their life cycle, by determining the transmission parameters and by developing disturbation strategies.
Development and industrial-scale application of a patentable procedure for objectively and reliably guaranteeing the hybrid nature of oil palm seeds, using molecular biology techniques.